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Abstract 
Attempts at using protein structures to identify disease-causing mutations have been dominated by the 
idea that most pathogenic mutations are disruptive at a structural level. Therefore, computational 
stability predictors, which assess whether a mutation is likely to be stabilising or destabilising to protein 
structure, have been commonly used when evaluating new candidate disease variants, despite not 
having been developed specifically for this purpose. We therefore tested 13 different stability predictors 
for their ability to discriminate between pathogenic and putatively benign missense variants. We find 
that one method, FoldX, significantly outperforms all other predictors in the identification of disease 
variants. Moreover, we demonstrate that employing predicted absolute energy change scores improves 
performance of nearly all predictors in distinguishing pathogenic from benign variants. Importantly, 
however, we observe that the utility of computational stability predictors is highly heterogeneous across 
different proteins, and that they are all inferior to the best performing variant effect predictors for 
identifying pathogenic mutations. We suggest that this is largely due to alternate molecular mechanisms 
other than protein destabilisation underlying many pathogenic mutations. Thus, better ways of 
incorporating protein structural information and molecular mechanisms into computational variant 
effect predictors will be required for improved disease variant prioritisation. 
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Introduction 
Advances in next generation sequencing technologies have revolutionised research of genetic variation, 
increasing our ability to explore the basis of human disorders and enabling huge databases covering 
both pathogenic and putatively benign variants1,2. Novel sequencing methodologies allow the rapid 
identification of variation in the clinic and are helping facilitate a paradigm shift towards precision 
medicine3,4. Despite this, however, it remains challenging to distinguish the small fraction of variants 
with medically relevant effects from the huge background of mostly benign human genetic variation. 
A particularly important research focus is single nucleotide variants that lead to amino acid substitutions 
at the protein level, i.e. missense mutations, which are associated with more than half of all known 
inherited diseases5,6. A large number of computational methods have been developed for the 
identification of potentially pathogenic missense mutations, i.e. variant effect predictors. Although 
different approaches vary in their implementation, a few types of information are most commonly used, 
including evolutionary conservation, changes in physiochemical properties of amino acids, biological 
function, known disease association and protein structure7. While these predictors are clearly useful for 
variant prioritisation, and show a statistically significant ability to distinguish known pathogenic from 
benign variants, they still make many incorrect predictions8–10, and the extent to which we can rely on 
them for aiding diagnosis remains limited11. 
An alternative approach to understanding the effects of missense mutations is with computational 
stability predictors. These are programs that have been developed to assess folding or protein 
interaction energy changes upon mutation (change in Gibbs free energy – ΔΔG in short). This can be 
achieved by approximating structural energy through linear physics-based pairwise energy scoring 
functions, their empirical and knowledge-based derivatives, or a mixture of such energy terms. 
Statistical and machine learning methods are employed to parametrise the scoring models. These 
predictors have largely been evaluated against their ability to predict experimentally determined ΔΔG 
values. Great effort has been previously made to assess stability predictor performance in producing 
accurate or well-correlated energy change estimates upon mutation, as well as assessing their shortfalls, 
such as biases arising from destabilising variant overrepresentation in training sets and lack of self-
consistency predicting forward-backward substitutions12–18. Several predictors have since been shown to 
alleviate such issues through their specific design or have been improved in this regard14,19,20. Moreover, 
the practical utility of stability predictors has been demonstrated through their extensive usage in the 
fields of protein engineering and design21–23. 
Although computational stability predictors have not been specifically designed to identify pathogenic 
mutations, they are very commonly used when assessing candidate disease mutations. For example, 
publications reporting novel variants will often include the output of stability predictors as evidence in 
support of pathogenicity24–27. This relies essentially upon the assumption that the molecular mechanism 
underlying many or most pathogenic mutations is directly related to the structural destabilisation of 
protein folding or interactions28–31. However, despite their widespread application to human variants, 
there has been little to no systematic assessment of computational stability predictors for their ability to 
predict disease mutations. A number of studies have assessed the real-world utility for individual protein 
targets and families using certain stability predictors32–36. However, numerous computational stability 
predictors have now been developed and, overall, we still do not have a good idea of which methods 
perform best for the identification of disease mutations, and how they compare relative to other 
computational variant effect predictors. 
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In this work, we explore the applicability and performance of 13 methodologically diverse structure-
based protein stability predictors for distinguishing between pathogenic and putatively benign missense 
mutations. We find that FoldX significantly outperforms all other stability predictors for the 
identification of disease mutations, and also demonstrate the practical value of using predicted absolute 
ΔΔG values to account for potentially overstabilising mutations. However, this work also highlights the 
limitations of stability predictors for predicting disease, as they still miss many pathogenic mutations 
and perform worse than many variant effect predictors, thus emphasising the importance of considering 
alternate molecular disease mechanisms beyond protein destabilisation.  
Results 
We tested 13 different computational stability predictors on the basis of accessibility, automation or 
batching potential, computation speed, as well as recognition – and included FoldX37, INPS3D38, 
Rosetta37, PoPMusic39, I-Mutant40, SDM41, SDM242, mCSM43, DUET44, CUPSAT45, MAESTRO46, ENCoM47 
and DynaMut48 (Table 1). We ran each predictor against 13,508 missense mutations from 96 different 
high-resolution (< 2 Å) crystal structures of disease-associated monomeric proteins. Our disease 
mutation dataset was comprised of 3,338 missense variants from ClinVar2 annotated as pathogenic or 
likely pathogenic, and we only included proteins with at least 10 known pathogenic missense mutations 
occurring at residues present in the structure. We compared these to 10,170 missense variants 
observed in the human population, taken from gnomAD v2.11, which we refer to as “putatively benign”. 
We acknowledge that it is likely that some of these gnomAD variants could be pathogenic under certain 
circumstances (e.g. if observed in a homozygous state, if they cause late-onset disease, or there is 
incomplete penetrance), or they may be damaging but lead to a subclinical phenotype. However, the 
large majority of gnomAD variants will be non-pathogenic, and we believe that our approach of 
represents a good test of the practical utilisation of variant effect predictors, where the main challenge 
is in distinguishing severe pathogenic mutations from others observed in the human population. While 
filtering by allele frequency would give us variants that are more likely to be truly benign, it would also 
dramatically reduce the size of the dataset (e.g. only ~1% of missense variants in gnomAD have an allele 
frequency >0.1%). Thus, we have not filtered the gnomAD variants (other than to exclude known 
pathogenic variants present in the ClinVar set). 
To investigate the utility of the computational stability predictors for the identification of pathogenic 
missense mutations, we used receiver operating characteristic (ROC) plots to assess the ability of ΔΔG 
values to distinguish between pathogenic and putatively benign mutations (Fig. 1A). This was quantifed 
by the area under the curve (AUC), which is equal to the probability of a randomly chosen disease 
mutation being assigned a higher-ranking score than a random benign one. Of the 13 tested structure-
based ΔΔG predictors, FoldX performs the best as a predictor of human missense mutation 
pathogenicity, with an AUC value of 0.661. This is followed by INPS3D at 0.640, Rosetta at 0.617 and 
PoPMusic at 0.614. Evaluating the performance through bootstrapping, we found that the difference 
between FoldX and other predictors is significant, with a p-value of 2 x 10-4 compared to INSP3D, 1 x 10-7 
for Rosetta and 8 x 10-9 for PoPMusiC. The remaining predictors show a wide range of lower 
performance values.  
Two predictors, ENCoM and DynaMut, stand out for their unusual pattern in the ROC plots, with a 
rotated sigmoidal shape where the false positive rate becomes greater than the true positive rate at 
higher levels. Close inspection of the underlying data shows that this is indicative of the predicted 
energy change distribution tails for the disease-associated class extending both directions away from the 
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putatively benign missense mutation score density. This suggests that a considerable portion of 
pathogenic missense mutations are predicted by these methods to excessively stabilise the protein. 
While the analysis (Fig. 1A) assumes that protein destabilisation should be indicative of mutation 
pathogenicity, it also possible for mutations that increase protein stability to cause disease49,50. Recent 
research has shown that absolute ΔΔG values, which treat stabilisation and destabilisation equivalently, 
may be better indicators of disease association51,52. Therefore, we repeated the analysis using absolute 
ΔΔG values (Fig. 1B). This improved the performance of most predictors, while not reducing the 
performance of any. The most drastic change was observed for ENCoM, which improved from worst to 
fifth best predictor, with an increase in AUC from 0.495 to 0.619. However, the top four predictors, 
FoldX, INPS3D, Rosetta and PoPMuSiC, improve only slightly and do not change in ranking.  
Using the ROC point distance to the top-left corner53, we establish the best disease classification ΔΔG 
value for each predictor when assessing general perturbation (Table 2). It is interesting to note that 
FoldX demonstrates the best classification performance when utilising 1.58 kcal/mol as the stability 
change threshold, which is remarkably close to the value of 1.5 kcal/mol previously suggested and used 
in a number of other works when assessing missense mutation impact on stability13,35,54. Of course, 
these threshold values should be considered far from absolute rules, and there are many pathogenic 
and benign mutations above and below the thresholds for all predictors. For example, nearly 40% of 
pathogenic missense mutations have FoldX values lower than the threshold, whereas approximately 
35% of putatively benign variants are above the threshold. 
To account for the class imbalance between putatively benign and pathogenic variants (roughly 3-to-1) 
in our dataset, we also performed precision-recall curve analysis. While the AUC of PR curves, unlike 
ROC, does not have a straightforward statistical interpretation, we again based the predictor 
performance according to this metric. From Fig. S1, it is apparent that the top four best predictors, 
according to both raw and absolute ΔΔG values, remain the same as in the ROC analysis – FoldX, INPS3D, 
Rosetta and PoPMuSiC, respectively.  
We also calculated ROC AUC values for each protein separately and compared the distributions across 
predictors (Fig. 2). FoldX again performs much better than other stability predictors for the identification 
of pathogenic mutations, with a mean ROC of 0.681, compared to INPS3D at 0.655, Rosetta at 0.627, 
PoPMuSiC at 0.621, and ENCoM at 0.630. Notably, the protein-specific performance was observed to be 
extremely heterogeneous across all predictors. While some predictors performed extremely well (AUC > 
0.9) for certain proteins, each predictor has a considerable number of proteins for which they perform 
worse than random classification (AUC < 0.5). 
Using the raw and absolute ΔΔG scores, we explored the similarities between different predictors by 
calculating Spearman correlations for all mutations between all pairs of predictors (Fig. S2). It is 
apparent that, outside of improved method versions and their predecessors, as well as consensus 
predictors and their input components, independent methods do not show correlations above 0.65. 
Furthermore, correlations on the absolute scale appear to slightly decrease in the majority of cases, with 
exceptions like ENCoM becoming more correlated with FoldX and INPS3D, while at the same time 
decoupling from DynaMut – a consensus predictor which uses it as input. Interestingly, FoldX and 
INSP3D, the best two methods, only correlate at 0.50 and 0.48 for raw and absolute ΔΔG values, 
respectively, which could indicate potential for deriving a more effective consensus methodology. 
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Finally, we compared the performance of protein stability predictors to a variety of different 
computational variant effect predictors (Fig. 3). Importantly, we excluded any predictors trained using 
supervised learning techniques, as well as meta-predictors that utilise the outputs of other predictors, 
thus including only predictors we labelled as unsupervised and empirical in our recent study10. This is 
due to the fact that predictors based upon supervised learning are likely to have been directly trained on 
some of the same mutations used in our evaluation dataset, making a fair comparison impossible10,55. A 
few predictors perform substantially better than FoldX, with the best performance seen for SIFT4G56, a 
modified version of the SIFT algorithm57. Interestingly, FoldX and INPS3D are the only stability predictors 
to outperform the BLOSUM62 substitution matrix58. On the other hand, all stability predictors 
performed better than a number of simple evolutionary constraint metrics. 
Discussion 
The first purpose of this study was to compare the abilities of different computational stability to 
distinguish between known pathogenic missense mutations and other putatively benign variants 
observed in the human population. In this regard, FoldX is the winner, clearly outperforming the other 
ΔΔG prediction tools. It also has the advantage of being computationally undemanding, fairly easy to 
run, and flexible in its utilisation. Compared to other methods that employ physics-based terms, FoldX 
introduces a few unique energy terms into its potential, notably the theoretically derived entropy costs 
for fixing backbone and side chain positions59. However, the main reason behind its success is likely the 
parametrisation of the scoring function, resulting from the well optimised design of the training and 
validation mutant sets, which aimed to cover all possible residue structural environments60. 
Interestingly, while the form of the FoldX function, consisting of mostly physics-based energy terms, has 
not seen much change over the years, newer knowledge-based methods, which leverage statistics 
derived from the abundant sequence and structure information, demonstrate poorer and highly varied 
performance. However, it is important to emphasise that the performance of FoldX does not necessarily 
mean that it is the best predictor of experimental ΔΔG values or true (de)stabilisation, as that is not 
what we are testing here. We also note the strong performance of INPS3D, which ranked a clear second 
in all tests. It has the advantage of being available as a webserver, thus making it simple for users to test 
small numbers of mutations without installing any software. 
There are two factors likely to be contributing to the improvement in the identification of pathogenic 
mutations using absolute ΔΔG values. First, while most focus in the past has been on destabilising 
mutations, some pathogenic missense mutations are known to stabilise protein structure. As an 
example, the H101Q variant of chloride intracellular channel 2 (CLIC2) protein, which is thought to play a 
role in calcium ion signalling, leads to developmental disabilities, increased risk to epilepsy and heart 
failure61. The CLIC2 protein is soluble, but requires insertion into the membrane for its function, with a 
flexible loop connecting its domains being functionally implicated in a necessary conformational 
rearrangement. The histidine to glutamine substitution, which occurs in the flexible loop, was predicted 
to have an overall stabilising energetic effect due to conservation of weak hydrogen bonding, but also 
the removal of charge that the protonated histidine exerted on the structure61. The ΔΔG predictions 
were followed up by molecular dynamics simulations, which supported the previous conclusions by 
showing reduced flexibility and movement of the N-terminus, with functional assays also revealing 
reduced membrane integration of the CLIC2 protein in line with the rigidification hypothesis62. However, 
other interesting examples of negative effects of over-stabilisation exist in enzymes and protein 
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complexes, manifesting through the activity-stability trade-off, rigidification of co-operative subunit 
movements, dysregulation of protein-protein interactions, and turnover49,50,63. 
In addition, it may be that some predictors are not as good at predicting the direction of the change in 
stability upon mutation. That is, they can predict structural perturbations that will be reflected in the 
magnitude of the ΔΔG value, but are less accurate in their prediction of whether this will be stabilising or 
destabilisng. For example, ENCoM and DynaMut predict nearly half of pathogenic missense mutations to 
be stabilising (41% and 44%, respectively), whereas FoldX predicts only 13%. While FoldX, Rosetta and 
PoPMuSiC are all driven by scoring functions consisting of a linear combination of physics- and statistics-
based energy terms, ENCoM is based on normal mode analysis, and relates the assessed entropy 
changes around equilibrium upon mutation to the state of free energy. DynaMut, a consensus method, 
integrates the output from ENCoM and several other predictors (Table 1) into its score48. The creators of 
ENCoM found that their method is less biased at predicting stabilising mutations64. From our analysis, 
we are unable to confidently say anything about what proportion of pathogenic mutations are stabilising 
vs destabilising, or about which methods are better at predicting the direction of stability change, but 
this is clearly an issue that needs more attention in the future. 
The second purpose of our study was to try to understand how useful protein stability predictors are for 
the identification of pathogenic missense mutations. Here, the answer is less clear. While all methods 
show some ability to discriminate between pathogenic and putatively benign variants, it is notable and 
perhaps surprising that all methods except FoldX and INPS3D performed worse than the simple 
BLOSUM62 substitution matrix, which suggests that these methods may be relatively limited utility for 
variant prioritisation. Even FoldX was unequivocally inferior to multiple variant effect predictors, 
suggesting that it should not be relied upon by itself for the identification of disease mutations. 
One reason for the limited success of stability predictors in the identification of disease mutations is that 
predictions of ΔΔG values are still far from perfect. For example, a number of studies have compared 
ΔΔG predictors, showing heterogeneous correlations with experimental values on the order of R=0.5 for 
many predictors12,13,65. However, a recent work has also revealed problems with the noise in 
experimental stability data used to benchmark the prediction methods, generally assessed through 
correlation values66. Taking noise and data distribution limitations into account, it is estimated that with 
currently available experimental data the best ΔΔG predictor output correlations should be in the range 
0.7-0.8, while higher values would suggest overfitting66. As such, even assuming that ‘true’ ΔΔG values 
were perfectly correlated with mutation pathogenicity, we would still expect these computational 
predictors to misclassify many variants. 
The existence of alternate molecular mechanisms underlying pathogenic missense mutations is also 
likely to be a major contributor to the underperformance of stability predictors compared to other 
variant effect predictors. At the simplest level, our analysis does not consider intermolecular 
interactions. Thus, given that pathogenic mutations are known to often occur at protein interfaces and 
disrupt interactions67,68, the stability predictors would not be likely to identify these mutations in this 
study. We tried to minimise the effects of this by only considering crystal structures of monomeric 
proteins, but the existence of a monomeric crystal structure does not mean that a protein does not 
participate in interactions. Fortunately, FoldX can be easily applied to protein complex structures, so the 
effects of mutations on complex stability can be assessed. 
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Pathogenic mutations that act via other mechanisms may also be missed by stability predictors. For 
example, we have previously shown that dominant-negative mutations in ITPR169 and gain-of-function 
mutations in PAX670 tend to be mild at a protein structural level. This is consistent with the simple fact 
that highly destabilising mutations would not be compatible with dominant-negative or gain-of-function 
mechanisms. Similarly, hypomorphic mutations that cause only a partial loss of function are also likely to 
be less disruptive to protein structure than complete loss-of-function missense mutations71. 
These varying molecular mechanisms are all likely to be related to the large heterogeneity in predictions 
we observe for different proteins in Fig 2. Similarly, the specific molecular and cellular contexts of 
different proteins could also limit the utility of ΔΔG values for predicting disease mutation. For example, 
even weak perturbations in haploinsufficient proteins could lead to a deleterious phenotype. At the 
same time, intrinsically stable proteins, proteins that are overabundant or functionally redundant could 
tolerate perturbing variants without such high ΔΔG variants being associated with disease. Finally, in 
some cases, mildly destabilising mutations can unfold local regions, leading to proteasome mediated 
degradation of the whole protein34,36,72. 
There could be considerable room for improvement in ΔΔG predictors and their applicability to disease 
mutation identification. Recently emerged hybrid methods, such as VIPUR73 and SNPMuSiC74, show 
promise of moving in the right direction, as they assess protein stability changes upon mutation while 
attempting to increase the interpretability and accuracy by taking the molecular and cellular contexts 
into account. However, none of the mentioned hybrid methods employ FoldX, which, given our findings 
here, may be a good strategy. Rosetta is also promising due to its tremendous benefit demonstrated in 
protein design. It should be noted that the protocol used for Rosetta in our work utilised rigid backbone 
parameters, due to the computation costs and time constraints involved in allowing backbone flexibility. 
An accuracy-oriented Rosetta protocol, or the “cartesian_ddg” application in the Rosetta suite, which 
allows structure energy minimisation in Cartesian space, may lead to better performance37,75.   
The ambiguity of the relationship between protein stability and function is exacerbated by the biases of 
the various stability prediction methods, which arise in their training, like overrepresentation of 
destabilising variants, dependence on crystal resolution and residue replacement asymmetry. Having 
observed protein-specific performance heterogeneity, we suggest that in the future focus could be 
shifted to identifying functional and structural properties of proteins, which could be most amenable to 
structure and stability-based prediction of mutation effects. Additionally, a recent work has showcased 
the use of homology models in structural analysis of missense mutation effects associated with disease, 
demonstrating utility that rivals experimentally derived structures, and thus expanding the possible 
resource pool that could be taken advantage of for structure-based disease prediction methods30. 
Further, our disease-associated mutations set likely contains variants causing disease through other 
mechanisms, that do not manifest through strong perturbation of the structure, making accurate 
evaluation impossible. To allow better stability-based predictors, it is important to have robust 
annotation of putative variant mechanisms, which is currently lacking due to non-existent experimental 
characterisation. We hope our results encourage new hybrid approaches, which make full use of the 
best available tools and resources to increase our ability to accurately prioritise putative disease 
mutations for further study, and elucidate the relationship between disease and stability changes. 
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Methods 
Pathogenic and likely pathogenic missense mutations were downloaded from the ClinVar2 database on 
2019-04-17, while putatively benign variants were taken from gnomAD v2.11. Any ClinVar mutations 
were excluded from the gnomAD set. We searched for human protein-coding genes with at least 10 
ClinVar mutations occurring at residues present in a single high-resolution (< 2 Å) crystal structure of a 
protein that is monomeric in its first biological assembly in the Protein Data Bank. We excluded non-
monomeric structures due to the fact that several of the computational predictors can only take a single 
polypeptide chain into consideration.  
FoldX 5.076 was run locally using default settings. Importantly, the ‘RepairPDB’ option was first used to 
repair all structures. Ten replicates were performed for each mutation to calculate the mean. 
The Rosetta suite (2019.14.60699 release build) was tested on structures first pre-minimised using the 
minimize_with_cst application and the following flags: -in:file:fullatom; -ignore_unrecognized_res -
fa_max_dis 9.0; -ddg::harmonic_ca_tether 0.5; -ddg::constraint_weight 1.0; -ddg::sc_min_only false. 
The ddg_monomer application was run according to a rigid backbone protocol with the following 
argument flags: -in:file:fullatom; -ddg:weight_file ref2015_soft; -ddg::iterations 50; -ddg::local_opt_only 
false; -ddg::min_cst false; -ddg::min true; -ddg::ramp_repulsive true ;-ignore_unrecognized_res. 
Predictions by ENCoM, DUET and SDM were extracted from the DynaMut results page, as it runs them 
as parts of its own scoring protocol. mCSM values from DynaMut coincided perfectly with values from 
the separate mCSM web server, and thus the server values were used, as DynaMut calculations yielded 
less results due to failing on more proteins.  
All other stability predictors were accessed through their online webservers with default settings by 
employing the Python RoboBrowser web scrapping library. Variant effect predictors were run in the 
same way as described in our recent benchmarking study10. 
Method performance was analysed in R using the PRROC77 and pROC78 packages, and AUC curve 
differences were statistically assessed through 10,000 bootstraps using the roc.test function of pROC. 
For DynaMut, I-Mutant 3.0, mCSM, SDM, SDM2 and DUET, the sign of the predicted stability score was 
inverted to match the convention of increased stability being denoted by a negative change in energy. 
For the precision-recall analysis, we used a subset of the mutation dataset, containing 9498 ClinVar and 
gnomAD variants, which had no missing prediction values for any of the stability-based methods. This is 
because a few of the predictors were unable to give predictions for all mutations (e.g. they crashed on 
certain structures), and for the precision-recall analysis, it is crucial that all predictors are tested on 
exactly the same dataset. We also show that the relative performance of the top predictors remains the 
same in the ROC analysis using this smaller dataset (Table S1). 
All mutations and corresponding structures and predictions are provided in Table S2. 
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Figure legends 
Figure 1: Using ΔΔG values from protein stability predictors to discriminate between pathogenic and 
putatively benign missense variants. Receiver operating characteristic (ROC) curves are plotted for each 
predictor, with the classification performance being presented next to its name in the form of area 
under the curve (AUC). A)  ROC curves for classification performance using native ΔΔG value scale for 
each predictor. B) ROC curves for predictor classification performance when using absolute ΔΔG values. 
The figure was generated in R v3.6.3 (https://www.r-project.org) using ggplot2 v3.3.0 
(https://ggplot2.tidyverse.org/), both freely available. 
 
Figure 2: The heterogeneity of protein-specific missense variant classification performance. All the 
stability predictors exhibit very high degrees of heterogeneity in their protein-specific performance, as 
measured by the ROC AUC on a per-protein basis. Absolute ΔΔG values were used during protein-
specific tool assessment. The mean performance of each predictor is indicated by a red dot and 
numerically showcased below the plot. Boxes inside the violins illustrate the interquartile range (IQR) of 
the protein-specific performance points, with the whiskers measuring 1.5 IQR. Boxplot outliers are 
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designated by black dots. The figure was generated in R v3.6.3 (https://www.r-project.org) using ggplot2 
v3.3.0 (https://ggplot2.tidyverse.org), both freely available. 
 
Figure 3: Performance comparison of protein stability and variant effect predictors for identifying 
pathogenic variants. Error bars indicate the 95% confidence interval of the ROC AUC as derived through 
bootstrapping. Stability predictors are shown in red, while other variant effect prediction methods are 
shown in green. Absolute ΔΔG values were used for stability-based methods. The figure was generated 
in R v3.6.3 (https://www.r-project.org) using ggplot2 v3.3.0 (https://ggplot2.tidyverse.org), both freely 
available. 
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Table 1. Protein stability predictors used in this study. 
Predictor Link Description 
DynaMut48 http://biosig.unimelb.edu.au/dynamut/ 
Consensus predictor which uses outputs from Bio3D, 
ENCoM and DUET to assess the impact of mutations on 
protein stability. Due to its nature, the predictor leverages 
multiple methodologies, such as normal mode analysis and 
statistical potentials.  
Ex
tr
ac
te
d 
fro
m
 D
yn
aM
ut
 ENCoM47 No longer available as a stand-alone server  
A prediction method based on normal mode analysis that 
relates changes in vibrational entropy upon mutation to 
changes in protein stability. Uses coarse-grained protein 
representations that accounts for residue properties. 
DUET44 http://biosig.unimelb.edu.au/duet/stability 
A machine-learnt consensus predictor that leverages 
output from SDM and mCSM, integrated using support 
vector machines. 
SDM41 No longer available as a stand-alone server (succeeded by the SDM2 webserver) 
A knowledge-based energy potential, derived using 
evolutionary environment-specific residue substitution 
propensities. 
FoldX76  http://foldxsuite.crg.eu/ 
A full-atom force field consisting of physics-based 
interaction and entropic terms, parametrised on empirical 
training data. Allows to easily run predictions on multi-
chain assemblies. 
Rosetta37 https://www.rosettacommons.org/home  
Rosetta macromolecular modelling software suite, which 
includes algorithms for stability impact prediction. Driven 
by a scoring function that is a linear combination of 
statistical and empirical energy terms. Highly modular and 
customisable. 
INPS3D38 https://inpsmd.biocomp.unibo.it/inpsSuite/default/index3D  
INPS3D builds upon its sequence and physicochemical 
conservation-based predecessor INPS, and employs 
structure-derived features such as solvent accessibility and 
local energy differences. The predictor is trained by 
employing support vector regression. 
mCSM43 http://biosig.unimelb.edu.au/mcsm/stability 
A machine-learned approach that evaluates structural 
signature changes imparted by mutations. Derives graph 
representation of physicochemical and geometric residue 
environment features. 
SDM242 http://marid.bioc.cam.ac.uk/sdm2/prediction 
Updated version of SDM, a knowledge-based potential, 
which uses environment-specific residue substitution 
tables, information on residue conformation and 
interactions, as well as packing density and residue depth, 
to assess protein stability changes. 
CUPSAT45 http://cupsat.tu-bs.de/  Prediction method that uses a residue torsion angle 
potential and an environment-specific atom pair potential 
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(an improvement upon amino acid potentials) to assess 
stability changes. 
PoPMuSiC39 https://soft.dezyme.com/query/create/pop 
A potential consisting of 13 statistical terms, volume 
difference between the wild-type and mutant residues, as 
well as the solvent accessibility of the original residue to 
differentiate core and surface substitutions.  
MAESTRO46 https://pbwww.che.sbg.ac.at/maestro/web 
Combines 3 statistical scoring functions of solvent exposure 
and residue pair distances, as well as 6 protein properties, 
in a machine-learning framework to derive a consensus 
stability impact prediction. 
I-Mutant 3.040 http://gpcr2.biocomp.unibo.it/cgi/predictors/I-Mutant3.0/I-Mutant3.0.cgi 
A machine-learning derived method that takes into account 
mutated residue spatial environment in terms of 
surrounding residue types and surface accessibility. 
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Table 2. Best stability predictor classification thresholds according to ‘distance-to-corner’ metric. The 
performance metrics and their 95% confidence intervals were derived from 2000 bootstraps of the data. 
Predictor Absolute ΔΔG threshold False positive rate (95% confidence interval) 
True positive rate (95% 
confidence interval) 
FoldX  1.578 0.339–0.357 0.591–0.624 
INPS3D 0.674 0.389–0.409 0.595–0.628 
Rosetta 1.886 0.390–0.409 0.572–0.605 
PoPMuSiC 0.795 0.417–0.437 0.584–0.618 
CUPSAT 1.455 0.415–0.434 0.549–0.583 
MAESTRO 0.321 0.418–0.437 0.544–0.578 
SDM 1.025 0.350–0.370 0.477–0.511 
SDM2 0.875 0.365–0.385 0.510–0.544 
mCSM 0.889 0.433–0.453 0.542–0.575 
DUET 0.803 0.400–0.421 0.548–0.582 
I-Mutant 3.0 0.915 0.405–0.424 0.545–0.578 
ENCoM 0.221 0.415–0.436 0.598–0.632 
DynaMut 0.476 0.446–0.467 0.570–0.605 
 
True positive rate
True positive rate
False positive rate
False positive rate
A
B
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Figure S1. Precision-recall analysis of predicted ΔΔG values. Precision-recall (PR) curves are plotted 
for each predictor, with the classification performance being presented next to its name in the form 
of area under the curve (AUC). The horizontal dashed line represents the baseline lowest 
performance of a predictor, derived from the two-class balance of the dataset, and here 
corresponds to ~0.3018. Due to the nature of PR analysis a downsized dataset was employed which 
contained only variants with no missing values for any predictor. A)  ROC curves for classification 
performance using raw ΔΔG value scale for each predictor. B) ROC curves for predictor classification 
performance when using absolute ΔΔG values. The figure was generated in R v3.6.3 (https://www.r-
project.org) using ggplot2 v3.3.0 (https://ggplot2.tidyverse.org/), both freely available. 
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Figure S2. Spearman rank correlation of predicted raw and absolute ΔΔG values between different 
stability prediction methods. The lower and upper triangles of the matrix represent raw and 
absolute ΔΔG value rank correlation. Crossed-out values indicate insignificant correlation. The figure 
was generated in R v3.6.3 (https://www.r-project.org) using corrplot v0.84 
(https://github.com/taiyun/corrplot), both freely available. 
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Table S1. Evaluation of predictor performance using raw and absolute ΔΔG values on the 
downsized missense variant dataset. DeLong approximation was used to derive the 95% confidence 
intervals for all the predictors. The dataset used was the same as for the precision-recall analysis, 
and contained no missing values for any predictors. 
Predictor AUC from raw ΔΔG (95% confidence interval) 
AUC from abs. ΔΔG (95% confidence 
interval) 
FoldX  0.658–0.683 0.664–0.688 
INPS3D 0.644–0.668 0.647–0.671 
Rosetta 0.611–0.636 0.621–0.646 
PoPMuSiC 0.617–0.641 0.621–0.646 
CUPSAT 0.574–0.600  0.596–0.622 
MAESTRO 0.533–0.559 0.544–0.569  
SDM 0.574–0.600 0.575–0.600 
SDM2 0.583–0.609 0.581–0.606 
mCSM 0.579–0.605 0.582–0.608 
DUET 0.595–0.620  0.599–0.623 
I-Mutant 3.0 0.602–0.626 0.602–0.627 
ENCoM 0.482–0.510 0.616–0.640 
DynaMut 0.515–542 0.573–0.598 
 
 
Table S2. Pathogenic and putatively benign missense variants used in this study, along with 
structures used and outputs from all predictors. 
Provided as a separate file ‘TableS2.xlsx’ 
